Granted Patent
B2
US 8,629,159 · App. 12/283,812 · Granted Jan 14, 2014
Thiazolidinedione analogues
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to thiazolidinedione analogues that are useful for treating hypertension.
Claims (3)
1. A method of treating or reducing the severity of hypertension comprising administering to a patient with hypertension a pharmaceutical composition comprising Compound No. 1
Compound No. 1
2. The method of claim 1 , wherein the pharmaceutical composition further comprises a diuretic, a statin, an ACE inhibitor, an ARB, a renin inhibitor, a β-adrenergic receptor blocker, an aldosterone receptor blocker, or combinations thereof.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY INTEREST
Recorded May 3, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: ALZHEIMER DRUG DISCOVERY FOUNDATION
Reel/Frame 038447/0317 →
SECURITY AGREEMENT
Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 13, 2010
From: COLCA, GERARD R.; KLETZIEN, ROLF F.
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY
Reel/Frame 024977/0455 →
Continuity (3)
Continuation In Part
PCTUS2007006385
· Mar 14, 2007
Provisional Application
60782787
· Mar 16, 2006